John D Kriesel

Title: John D Kriesel: Innovator in Viral Therapeutics

Introduction

John D Kriesel is a notable inventor based in Holladay, UT (US). He has made significant contributions to the field of viral therapeutics, holding 2 patents that focus on the diagnosis and treatment of herpes simplex virus diseases. His work has implications for both medical research and therapeutic applications.

Latest Patents

Kriesel's latest patents include innovative methods for addressing herpes simplex labialis (HSL). The first patent, titled "Diagnosis and treatment of herpes simplex virus diseases," maps a susceptibility gene associated with HSL to the q11 region of chromosome 21. This invention provides methods for screening susceptibility or resistance to herpes simplex virus, particularly HSL, and diagnosing related herpetic diseases. The second patent, "Oligonucleotide complexes for use as anti-viral therapeutics," outlines methods for targeting transcription-altering agents to specific sites in viral genomes. This approach aims to inactivate viruses and can be applied against various viral pathogens, including those that may be used in bioterrorism.

Career Highlights

Throughout his career, John D Kriesel has worked with esteemed institutions such as the University of Utah Research Foundation and Yale University. His research has contributed to advancements in understanding and treating viral infections, particularly those caused by herpes simplex viruses.

Collaborations

Kriesel has collaborated with notable colleagues, including Brandt B Jones and Mark F Leppert. These partnerships have enhanced his research efforts and expanded the impact of his inventions.

Conclusion

John D Kriesel is a distinguished inventor whose work in viral therapeutics has the potential to transform the diagnosis and treatment of herpes simplex virus diseases. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.